Objective To study the effect of levothyroxine sodium tablets on the growth and development and thyroid function in preterm infants with thyroid dysfunction. Methods A retrospective analysis was performed for 82 preterm infants who were born in the Department of Obstetrics of the First People's Hospital of Yunnan Province, from January 1, 2013 to December 31, 2017, and these infants were hospitalized after birth in the Department of Neonatology of the hospital. They were regularly followed up to observe growth and development and thyroid function at the outpatient service of the Department of Neonatology. According to thyroid function test results, they were divided into an abnormal thyroid function group (observation group; n=31) and a normal thyroid function group (control group; n=51). The infants in the observation group were given oral administration of levothyroxine sodium tablets, while those in the control group were not given any treatment. The two groups were compared in terms of the physical and intelligence development and thyroid function of preterm infants with various gestational ages (28-<32 weeks, 32-<34 weeks, and 34-<37 weeks) after regular follow-up to the corrected age of 12 months. Results There were no significant differences in physical development indices (body length, body weight, and head circumference) between the observation and control groups at various gestational ages after follow-up to the corrected age of 12 months (P>0.05). There were no significant differences between the two groups in the scores of each functional area of the Gesell Developmental Scale among the preterm infants with a gestational age of 28-<32 weeks and 32-<34 weeks after follow-up to the corrected age of 12 months (P>0.05). For the preterm infants with a gestational age of 34-<37 weeks, compared with the control group, the observation group had a significantly lower score of gross motor ability at the age of 3 and 12 months, significantly lower scores of fine motor ability, language ability, and adaptation ability at the age of 12 months (P<0.05), and a significantly lower score of personal-social ability at the age of 3 months (P<0.05). However, the score of personal-social ability in the observation group was not significantly different from the control group at the age of 12 months (P>0.05). After 2-4 weeks of treatment with levothyroxine sodium tablets, the thyroid function of the 31 preterm infants with thyroid dysfunction returned to normal. Among the 31 infants, 21 (68%) achieved complete drug withdrawal, with normal results of neonatal screening (100%); 10 infants (32%) failed to achieve drug withdrawal, and only 2 (20%) out of the 10 infants had normal neonatal screening results (P<0.05). Conclusions Early diagnosis and reasonable treatment can reduce the impact on growth and development in preterm infants with thyroid dysfunction. Most preterm infants tend to have transient thyroid dysfunction, while those with positive results of neonatal screening are more likely to develop permanent thyroid dysfunction.
Key words
Thyroid dysfunction /
Intelligence development /
Physical development /
Preterm infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 陈锐, 梁睿, 吴学威, 等. 中山地区新生儿先天性甲状腺功能减低症筛查结果分析[J]. 检验医学与临床, 2020, 17(8): 1009-1011. DOI: 10.3969/j.issn.1672-9455.2020.08.001.
2 Pierrat V, Marchand-Martin L, Arnaud C, et al. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study[J]. BMJ, 2017, 358: j3448. PMID: 28814566. PMCID: PMC5558213. DOI: 10.1136/bmj.j3448.
3 Hashemipour M, Hovsepian S, Ansari A, et al. Screening of congenital hypothyroidism in preterm, low birth weight and very low birth weight neonates: a systematic review[J]. Pediatr Neonatol, 2018, 59(1): 3-14. PMID: 28811156. DOI: 10.1016/j.pedneo.2017.04.006.
4 张靖辉, 李利. 早产儿甲状腺功能紊乱研究进展[J]. 中国新生儿科杂志, 2016, 31(3): 227-230. DOI: 10.3969/j.issn.1673-6710.2016.03.016.
5 范惠霞, 高苗苗, 阎亚琼, 等. 先天性甲状腺功能减低症不同转归的早期预测因子探讨[J]. 中华全科医师杂志, 2020, 19(12): 1141-1146. DOI: 10.3760/cma.j.cn114798-20200726-00857.
6 Kilberg MJ, Rasooly IR, LaFranchi SH, et al. Newborn screening in the US may miss mild persistent hypothyroidism[J]. J Pediatr, 2018, 192: 204-208. PMID: 29246344. PMCID: PMC5823276. DOI: 10.1016/j.jpeds.2017.09.003.
7 LaFranchi SH. Screening preterm infants for congenital hypothyroidism: better the second time around[J]. J Pediatr, 2014, 164(6): 1259-1261. PMID: 24657124. DOI: 10.1016/j.jpeds.2014.02.031.
8 Eng L, Lam L. Thyroid function during the fetal and neonatal periods[J]. Neoreviews, 2020, 21(1): e30-e36. PMID: 31894080. DOI: 10.1542/neo.21-1-e30.
9 《中华儿科杂志》编辑委员会, 中华医学会儿科学分会新生儿学组, 中华医学会儿科学分会儿童保健学组. 早产/低出生体重儿喂养建议[J]. 中华儿科杂志, 2009, 47(7): 508-510. DOI: 10.3760/cma.j.issn.0578-1310.2009.07.007.
10 《中华儿科杂志》编辑委员会, 中华医学会儿科学分会儿童保健学组, 中华医学会儿科学分会新生儿学组. 早产、低出生体重儿出院后喂养建议[J]. 中华儿科杂志, 2016, 54(1): 6-12. PMID: 27470474. DOI: 10.3760/cma.j.issn.0578-1310.2016.01.003.
11 中华医学会儿科学分会内分泌遗传代谢学组, 中华预防医学会儿童保健分会新生儿疾病筛查学组. 先天性甲状腺功能减低症诊疗共识[J]. 中华儿科杂志, 2011, 49(6): 421-424. DOI: 10.3760/cma.j.issn.0578-1310.2011.06.006.
12 中华人民共和国国家卫生健康委员会妇幼保健与社区卫生司. 卫生部关于印发《新生儿疾病筛查技术规范(2010年版)》的通知: 卫妇社发〔2010〕96号[EB/OL]. (2010-12-01)[2020-11-13]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=50065.
13 王卫平, 孙锟, 常立文. 儿科学[M]. 9版. 北京: 人民卫生出版社, 2018: 86.
14 Kaluarachchi DC, Allen DB, Eickhoff JC, et al. Increased congenital hypothyroidism detection in preterm infants with serial newborn screening[J]. J Pediatr, 2019, 207: 220-225. PMID: 30579585. DOI: 10.1016/j.jpeds.2018.11.044.
15 Jaruratanasirikul S, Janjindamai W, Sriplung H. Congenital hypothyroidism in preterm infants: a 3- to 8-year longitudinal study in southern Thailand[J]. J Pediatr Endocrinol Metab, 2019, 32(11): 1275-1282. PMID: 31465294. DOI: 10.1515/jpem-2019-0054.
16 叶梅玲, 周彩玲, 王灵华. 早产儿发生甲状腺功能低下的相关因素[J]. 中国妇幼保健, 2017, 32(15): 3579-3581. DOI: 10.7620/zgfybj.j.issn.1001-4411.2017.15.62.
17 胡晓晶, 耿秋菊, 李红, 等. 左甲状腺素对早产儿暂时性低甲状腺素血症的治疗价值[J]. 中国生育健康杂志, 2019, 30(5): 468-470. DOI: 10.3969/j.issn.1671-878X.2019.05.017.
18 Williams FLR, Visser TJ, Hume R. Transient hypothyroxinaemia in preterm infants[J]. Early Hum Dev, 2006, 82(12): 797-802. PMID: 17079099. DOI: 10.1016/j.earlhumdev.2006.09.007.
19 Ford G, LaFranchi SH. Screening for congenital hypothyroidism: a worldwide view of strategies[J]. Best Pract Res Clin Endocrinol Metab, 2014, 28(2): 175-187. PMID: 24629860. DOI: 10.1016/j.beem.2013.05.008.
20 Bulu? AD, Tiftik E. Evaluation of neurodevelopment of children with congenital hypothyroidism by the Denver Developmental Screening Test[J]. J Pediatr Endocrinol Metab, 2017, 30(10): 1061-1066. PMID: 28917084. DOI: 10.1515/jpem-2016-0188.
21 Albert BB, Heather N, Derraik JGB, et al. Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring[J]. J Clin Endocrinol Metab, 2013, 98(9): 3663-3670. PMID: 23861458. DOI: 10.1210/jc.2013-1903.
22 杨景晖, 张靖辉, 章印红, 等. 云南省部分地区先天性甲状腺功能减低症治疗效果分析[J]. 中国当代儿科杂志, 2017, 19(7): 741-747. PMID: 28697824. PMCID: PMC7389930. DOI: 10.7499/j.issn.1008-8830.2017.07.003.
23 王秀利, 彭磊, 杨丹艳, 等. 先天性甲状腺功能减低症筛查及治疗效果分析[J]. 临床儿科杂志, 2016, 34(8): 602-605. DOI: 10.3969/j.issn.1000-3606.2016.08.010.
24 Seo MK, Yoon JS, So CH, et al. Intellectual development in preschool children with early treated congenital hypothyroidism[J]. Ann Pediatr Endocrinol Metab, 2017, 22(2): 102-107. PMID: 28690988. PMCID: PMC5495975. DOI: 10.6065/apem.2017.22.2.102.
25 Aleksander PE, Brückner-Spieler M, Stoehr AM, et al. Mean high-dose l-thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism[J]. J Clin Endocrinol Metab, 2018, 103(4): 1459-1469. PMID: 29325045. DOI: 10.1210/jc.2017-01937.
26 Lam?nica DAC, Anastácio-Pessan FDL, Ferraz PMDP, et al. Performance in motor, communicative and cognitive skills of girls with congenital hypothyroidism treated from the neonatal period[J]. Codas, 2020, 32(1): e20190017. PMID: 32049153. DOI: 10.1590/2317-1782/20192019017.
27 Rovet JF. Children with congenital hypothyroidism and their siblings: do they really differ?[J]. Pediatrics, 2005, 115(1): e52-e57. PMID: 15629966. DOI: 10.1542/peds.2004-1492.
28 安振存. 先天性甲状腺功能减低症对儿童生长发育的影响[J]. 中华灾害救援医学, 2020, 8(4): 228-230. DOI: 10.13919/j.issn.2095-6274.2020.04.017.
29 Nú?ez A, Bedregal P, Becerra C, et al. Neurodevelopmental assessment of patients with congenital hypothyroidism[J]. Rev Med Chil, 2017, 145(12): 1579-1587. PMID: 29652955. DOI: 10.4067/s0034-98872017001201579.
30 Frezzato RC, Santos DCC, Goto MMF, et al. Fine motor skills and expressive language: a study with children with congenital hypotyreoidism[J]. Codas, 2017, 29(1): e20160064. PMID: 28300959. DOI: 10.1590/2317-1782/20172016064.
31 Olivieri A, Fazzini C, Medda E, et al. Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening[J]. Horm Res Paediatr, 2015, 83(2): 86-93. PMID: 25572470. DOI: 10.1159/000369394.
32 杨茹莱, 童凡, 徐艳华, 等. 先天性甲状腺功能低下症2 789例诊断标准与治疗探讨及预后研究[J]. 中国儿童保健杂志, 2017, 25(11): 1094-1097. DOI: 10.11852/zgetbjzz2017-25-11-04.
PDF(635 KB)
